DOI: 10.1055/s-00000133

Gastroenterologie up2date

LinksSchließen

Referenz

Grothey A, Jordan K, Kellner O. et al.
Randomized phase II trial of capecitabine plus irinotecan (CapIri) vs capecitabine plus oxaliplatin (CaPox) as first line therapy of advanced colorectal cancer (ACRC). 
Proc Am Soc Clin Oncol 2003; 23: 255-  

Bibliographische Angaben herunterladen

Suchen in: